Literature DB >> 184383

Concentration of 3', 5' cyclic adenosine monophosphate in ventricular cerebrospinal fluid of patients with prolonged coma after head trauma or intracranial hemorrhage.

D Rudman, A Fleischer, M H Kutner.   

Abstract

A previous study showed that cerebrospinal fluid from the lateral ventricle of patients without disturbance of sensorium or intracranial pressure contains 15 to 30 nm 3', 5' cyclic adenosine monophosphate. We measured the concentration of this cyclic nucleotide by radioimmunoassay in cerebrospinal fluid from the lateral ventricle of six patients with prolonged coma (20 days or longer) after head trauma (four), or spontaneous intracranial hemorrhage (two). Coma was graded IV to I in order of decreasing severity. Fluid was removed at intervals of six to 72 hours from a Rickham reservoir placed in the lateral ventricle. Concentration of the cyclic nucleotide (mean +/- S.E.M.) in coma of Grades IV, III, II and I was 2.1 +/- 0.3, 4.6 +/- 0.5, 6.3 +/- 1.4 and 12.5 +/- 2.4 nM respectively. After sensorium became normal, cAMP was 21.0 +/- 1.4 nM. Correlation between grade of coma and concentration was -0.89 (P less than 0.01). Thus, prolonged coma appears to be associated with a disturbance of cyclic AMP metabolism within the central nervous system.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 184383     DOI: 10.1056/NEJM197609162951202

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


  6 in total

1.  Cerebrospinal fluid cyclic AMP and acid monoamine metabolites following probenecid: studies in psychiatric patients.

Authors:  M B Bowers; R E Study
Journal:  Psychopharmacology (Berl)       Date:  1979-03-29       Impact factor: 4.530

2.  CSF cyclic AMP and CSF adenylate kinase in cerebral ischaemic infarction.

Authors:  T Büttner; C R Hornig; O Busse; W Dorndorf
Journal:  J Neurol       Date:  1986-10       Impact factor: 4.849

3.  Decreased cerebrospinal fluid cyclic adenosine 3',5'-monophosphate in bacterial meningitis.

Authors:  S Weitzman; L B Palmer; S A Berger
Journal:  J Clin Microbiol       Date:  1979-03       Impact factor: 5.948

Review 4.  Biomarkers for the diagnosis, prognosis, and evaluation of treatment efficacy for traumatic brain injury.

Authors:  Pramod K Dash; Jing Zhao; Georgene Hergenroeder; Anthony N Moore
Journal:  Neurotherapeutics       Date:  2010-01       Impact factor: 7.620

5.  Cyclic nucleotides in experimental and human brain tumors.

Authors:  G Racagni; S Pezzotta; M T Giordana; E Iuliano; I Mocchetti; G Spanu; G Sangiovanni; P Paoletti
Journal:  J Neurooncol       Date:  1983       Impact factor: 4.130

6.  Adenosine neuromodulation and traumatic brain injury.

Authors:  T A Lusardi
Journal:  Curr Neuropharmacol       Date:  2009-09       Impact factor: 7.363

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.